logo

NMTC

NeuroOne Medical
--
--(--)
Market Open: --
--
--(--)
Post-Market: --

NMTC fundamentals

NeuroOne Medical (NMTC) expects to report earnings on Aug 13, 2025, with estimated revenue of 1.82M (YoY +120.40%), and EPS at -- (YoY 0.00%).
Revenue estimate / YoY
1.82M
+120.40%
EPS estimate / YoY
--
0.00%
Report date
Aug 13, 2025
EPS
Revenue

Revenue & Expenses

NMTC has released its 2025 Q2 earnings report, with revenue of 1.39M, reflecting a YoY change of 0.67%, and net profit of -2.27M, showing a YoY change of 20.47%. The Sankey diagram below clearly presents NMTC's revenue sources and cost distribution.

Key Indicators

NeuroOne Medical (NMTC) key financial stats and ratios, covering profitability, financial health, and leverage.
NeuroOne Medical (NMTC)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
NeuroOne Medical (NMTC)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
NeuroOne Medical (NMTC)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does NeuroOne Medical (NMTC) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track NeuroOne Medical (NMTC) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield